Research Compound Summary Compound: Retatrutide CAS Number: 2381089-83-2 Molecular Formula: C205H320N56O63S2 Purity: 99.71% (HPLC-UV verified) Third-Party Testing: Testides Analytical (independent lab, Toronto) COA Download: View Full COA (PDF) Report: DBAV-RETA-10-062726 Source: Canadian manufactured Shipping: Same-day from our BC facility Retatrutide peptide Canada: a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously
User reports suggest 60 to 70% of people with moderate elbow tendinopathy experience clear benefit, with 30 to 40% describing their results as dramatic
Due to the risk of thyroid cancer, it is recommended not to take Rybelsus for patients with a personal or family history of thyroid cancer
The supplement is free of artificial colors, flavors, sweeteners, and preservatives, and is produced in a GMP-certified facility to ensure its safety and efficacy
Shilpy Bhandari - August 05, 2024 Cleft lip and palate are birth defects that affect the development of the upper lip and roof of the mouth (palate) respectively, resulting in a visible separation in these areas
Our team encourages all researchers to approach their studies with an unflinching commitment to safety and ethical practices